论文部分内容阅读
<正>Along with molecular targeted drugs and antibody-drug conjugates(ADC),cancer nanomedicine has now been considered as one of the troika for advanced cancer treatment by delivering anticancer drugs to the tumor site with reduced side effects and enhanced therapeutic efficacy[1].As researchers learn more about cancer drug delivery process and tumor microenvironment[2],it is now recog-